Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinson’s Dis. 2018;8(s1):S3-8.

Article  Google Scholar 

Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1083–97.

Article  Google Scholar 

Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D, et al. Racial and ethnic estimates of Alzheimer’s disease and related dementias in the United States (2015–2060) in adults aged ≥65 years. Alzheimer’s & Dementia. 2019;15(1):17–24.

Article  Google Scholar 

Nichols E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88–106.

Article  Google Scholar 

Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. npj Parkinson’s Dis. 2020;6(1).

Nalls MA, Blauwendraat C, Sargent L, Vitale D, Leonard H, Iwaki H, et al. Evidence for GRN connecting multiple neurodegenerative diseases. Brain Commun. 2021;3(2).

Brouwers N, Nuytemans K, Julie Z, Gijselinck I, Engelborghs S, Theuns J, et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol. 2007;64(10):1436–46.

Article  PubMed  Google Scholar 

Brouwers N, Sleegers K, Engelborghs S, Maurer-Stroh S, Gijselinck I, van der Zee J, et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology. 2008;71(9):656–64.

Article  CAS  PubMed  Google Scholar 

Cortini F, Fenoglio C, Guidi I, Venturelli E, Pomati S, Marcone A, et al. Novel exon 1 progranulin gene variant in Alzheimer’s disease. Eur J Neurol. 2008;15(10):1111–7.

Article  CAS  PubMed  Google Scholar 

Fenoglio C, Galimberti D, Cortini F, Kauwe JSK, Cruchaga C, Venturelli E, et al. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer’s disease. J Alzheimer’s Dis. 2009;18(3):603–12.

Article  CAS  Google Scholar 

Kämäläinen A, Viswanathan J, Natunen T, Helisalmi S, Kauppinen T, Pikkarainen M, et al. GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer’s disease patients. J Alzheimer’s Dis. 2012;33(1):23–7.

Article  Google Scholar 

Lee MJ, Chen TF, Cheng TH, Chiu MJ. rs5848 variant of progranulin gene is a risk of Alzheimer’s disease in the Taiwanese population. Neurodegener Dis. 2011;8(4):216–20.

Article  CAS  PubMed  Google Scholar 

Leverenz JB, Yu CE, Montine TJ, Steinbart E, Bekris LM, Zabetian C, et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain. 2007;130(5):1360–74.

Article  CAS  PubMed  Google Scholar 

Yongdui C, Li S, Su L, Sheng J, Wen L, Chen G, et al. Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis. J Neurol. 2015;262(4):814–22.

Article  Google Scholar 

Murthy M, Blauwendraat C, Ukbec GS, Ipdgc HJ, et al. Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3. Neurogenetics. 2017;18(3):121–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumaran R, Cookson MR. Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson’s disease. Hum Mol Genet. 2015;24(R1):R32-44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang M, Modeste E, Dammer E, Merino P, Taylor G, Duong DM, et al. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations. Acta Neuropathol Commun. 2020;8(1).

Lui H, Zhang J, Makinson Stefanie R, Cahill Michelle K, Kelley Kevin W, Huang HY, et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell. 2016;165(4):921–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hrabal R, Chen Z, James S, Bennett, Ni F. The hairpin stack fold, a novel protein architecture for a new family of protein growth factors. Nat Struct Mol Biol. 1996;3(9):747–52.

Article  CAS  Google Scholar 

Lee WC, Almeida S, Prudencio M, Caulfield TR, Zhang YJ, Tay WM, et al. Targeted manipulation of the sortilin–progranulin axis rescues progranulin haploinsufficiency. Hum Mol Genet. 2013;23(6):1467–78.

Article  PubMed  PubMed Central  Google Scholar 

Zhou X, Sullivan PM, Sun L, Hu F. The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C. J Neurochem. 2017;143(2):236–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee CW, Stankowski JN, Chew J, Cook CN, Lam YW, Almeida S, et al. The lysosomal protein cathepsin L is a progranulin protease. Mol Neurodegeneration. 2017;12(1).

Zhou X, Paushter DH, Feng T, Sun L, Reinheckel T, Hu F. Lysosomal processing of progranulin. Mol Neurodegeneration. 2017;12(1).

Holler CJ, Taylor G, Deng Q, Kukar T. Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations. eneuro. 2017;4(4):ENEURO.0100-17.2017.

Suh HS, Choi N, Tarassishin L, Lee SC. Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12). PLoS ONE. 2012;7(4):e35115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo FJ, Lai Y, Tian Q, Lin E, Kong L, Liu C. Granulin-epithelin precursor (GEP) binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis Rheumatism. 2010;62(7):2023.

Article  CAS  PubMed  Google Scholar 

Kessenbrock K, Fröhlich LF, Sixt M, Lämmermann T, Pfister H, Bateman A, et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008;118(7).

Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, et al. Conversion of proepithelin to epithelins. Cell. 2002;111(6):867–78.

Article  CAS  PubMed  Google Scholar 

Du H, Zhou X, Feng T, Hu F. Regulation of lysosomal trafficking of progranulin by sortilin and prosaposin. Brain Commun. 2022;4(1).

Nguyen A, Nguyen T, Basar Cenik YuG, Herz J, Walther TC, et al. Secreted progranulin is a homodimer and is not a component of high density lipoproteins (HDL). J Biol Chem. 2013;288(12):8627–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galimberti D, Fumagalli G, Fenoglio C, Cioffi S, Arighi A, Serpente M, et al. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study. Neurobiol Aging. 2018;62(245):e9-12.

Google Scholar 

Sellami L, Rucheton B, Younes IB, Camuzat A, Saracino D, Rinaldi D, et al. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience. Neurobiol Aging. 2020;91:167.

Article  Google Scholar 

Root J, Merino P, Nuckols A, Johnson M, Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;154: 105360.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao YN, Wang MD, Tang XC, Wu B, Sun HM. Reduced plasma progranulin levels are associated with the severity of Parkinson’s disease. Neurosci Lett. 2020;725: 134873.

Article  CAS  PubMed  Google Scholar 

Zhou X, Sun L, Bracko O, Choi JW, Jia Y, Nana AL, et al. Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations. Nat Commun. 2017;8(1).

Ong C, He Z, Kriazhev L, Shan X, Roger BA. Regulation of progranulin expression in myeloid cells. Am J Physiol Regul Integr Comp Physiol. 2006;291(6):R1602–12.

Article  CAS  PubMed  Google Scholar 

Kawashima K, Ishiuchi Y, Konnai M, Komatsu S, Sato H, Kawaguchi H, et al. Glucose deprivation regulates the progranulin-sortilin axis in PC12 cells. FEBS Open Bio. 2016;7(2):149–59.

Article  PubMed  PubMed Central  Google Scholar 

Menzel L, Kleber L, Friedrich C, Hummel R, Dangel L, Winter J, et al. Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury. Glia. 2016;65(2):278–92.

Article  PubMed  Google Scholar 

Chen-Plotkin A, Martinez-Lage M, Patrick, Hu WT, Greene R, Wood EM, et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011;68(4):488–98.

Article  PubMed  PubMed Central  Google Scholar 

Shankaran SS, Capell A, Hruscha AT, Fellerer K, Neumann M, Schmid B, et al. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J Biol Chem. 2007;283(3):1744–53.

Article  PubMed  Google Scholar 

Puoti G, Lerza MC, Ferretti MG, Bugiani O, Tagliavini F, Rossi G. A Mutation in the 5′-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms. J Alzheimer’s Dis. 2014;42(3):939–47.

Article  CAS  Google Scholar 

Capell A, Fellerer K, Haass C. Progranulin transcripts with short and long 5′ untranslated regions (UTRs) are differentially expressed via posttranscriptional and translational repression. J Biol Chem. 2014;289(37):25879–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Banzhaf-Strathmann J, Claus R, Mücke O, Rentzsch K, van der Zee J, Engelborghs S, et al. Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathol Commun. 2013;1(1).

Jiao J, Herl L, Farese RV, Gao FB. MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia. PLoS ONE. 2010;5(5):e10551–61.

Article  PubMed  PubMed Central  Google Scholar 

Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln S, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet. 2008;17(23):3631–42.

Article  CAS